60.90 0.00 (0.00%)
After hours: 4:17PM EDT
|Bid||60.81 x 800|
|Ask||60.84 x 800|
|Day's Range||60.21 - 60.95|
|52 Week Range||53.78 - 63.73|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||62.78|
Novartis AG (NVS) gained 1.1% so far in trading this week. Plus, the Swiss multinational pharmaceutical company has been on a tear since the end of April, up 18.2%. Now let's see what investors should expect heading into its Q2 2019 earnings release on Thursday.
Alcon, the global leader in eye care, is kicking off a new program from SYSTANE® aimed at funding women entrepreneurs and their business ideas. Launched in partnership with iFundWomen, a crowdfunding platform designed for female entrepreneurs, Real Relief for Visionary Women will give applicants an opportunity to be considered for financial relief and expert coaching for their business ventures. Barbara Corcoran, businesswoman and TV personality, teamed up with SYSTANE® since she knows firsthand how small things can make the difference in launching and sustaining a successful business – whether it’s seed funding, strong mentorship or not losing your focus due to dry eye symptoms.
Alcon, the global leader in eye care, today announced the debut of DAILIES® COLORS contact lenses that combine the beauty of eye color enhancement with the convenience of a daily disposable contact lens. The new line features four colors – Mystic Blue, Mystic Gray, Mystic Hazel and Mystic Green* – introduced at a time when color contact lenses are re-emerging as an easy and creative way to express personal style.
Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. The meeting is taking place June 19-23 at the America’s Center Convention Complex (ACCC) in St. Louis, Missouri.
Alcon, the global leader in eye care, is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1® contact lenses have helped her maintain the focus and enthusiasm needed to get to the top of her game. This campaign is rolling out during a pivotal time for Laurie, as she prepares to compete in next year’s games in Tokyo.
GENEVA-- -- First quarter sales of $1.8 billion, flat to last year; an increase of 4% constant currency Healthy momentum in Surgical business, with 2% growth and 7% constant currency growth Full year 2019 outlook of 3% to 5% constant currency net sales growth and 17% to 18% core operating margin Regulatory News: Alcon , the global leader in eye care, today reported selected financial results for the ...
Alcon Inc. (ALC) is a leading eye care company. Investors may be most familiar with its Opti- Free branded contact lens solution, but it also has exposure to the surgical area. The business is divided into two segments, surgical (about 55% of sales) and vision care (45% of sales).
GENEVA-- -- Large scientific program will reinforce the ongoing clinical and patient benefits of its robust portfolio Highlights include new product launches in phacoemulsification, visualization for the Cataract Refractive Suite and innovations in intraoperative aberrometry and AT-IOLs Onsite events for surgeons demonstrate Alcon’s continued commitment to world-class training, education Alcon, the ...
Health-care earnings begin in earnest this week. Centene Corp. reported on Tuesday, and Anthem Inc., Biogen Inc., Boston Scientific Corp. and Novartis AG are set to report Wednesday.
Alcon (ALC.SW) (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will provide a trading update and host a conference call on Thursday, May 16, at 3:00 p.m. Central European Time / 8 a.m. Central Time for the quarter ended March 31, 2019. This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Alcon. This publication may contain certain forward-looking statements concerning the Company and its business.
This weekend's Barron's cover story offers a look at a company set to shake up health care. Other featured articles examine prospects for oil drillers as takeover targets and for dividend growth stocks. ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 11) Edap Tms SA (NASDAQ: EDAP ) Down In The Dumps (Biotech ...
Novartis news about the company's spin-off of Alcon has NVS stock down on Tuesday.Source: Shutterstock Novartis (NYSE:NVS) announced on Tuesday that it has completed its spin-off of Alcon. This has the stock now trading on the New York Stock Exchange under the stock ticker of "ALC." It is also trading under this ticker on the SIX Swiss Exchange. There is no change to the tickers for NVS stock on either exchange.The Novartis news about the spin-off had the company completing the action through a dividend-in-kind distribution. This means that the Alcon (NYSE:ALC) spin-off saw investors in NVS stock gain shares of ALC stock. The rate was one share of ALC stock for each five shares of NVS stock held by an investor.InvestorPlace - Stock Market News, Stock Advice & Trading TipsNovartis notes that the spin-off of Alcon has the company better aligning its portfolio with those of its peers in the pharmaceutical industry. This will allow to to focus its capital allocation and management attention on medicines. * 8 Risky Stocks to Watch as Earnings Season Kicks Off "At Novartis, we continue to reimagine ourselves as a leading medicines company powered by breakthrough medicines, data science and advanced therapy platforms," Vas Narasimhan, CEO of Novartis, said in a statement. "We are well positioned for the future and I am excited for our associates, our investors, and most importantly for patients."NVS stock was down 11% as of Tuesday morning, but is up nearly 13% since the start of the year. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Medical Marijuana Stocks to Cure Your Portfolio * 8 Best Stocks to Buy for an April Rally * Top 20 Stocks to Buy for 20-Somethings! As of this writing, William White did not hold a position in any of the aforementioned securities.Compare Brokers The post Novartis News: NVS Stock Sinks Following Alcon Spin-Off appeared first on InvestorPlace.
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its debut as an independent, publicly traded company and the completion of its separation from Novartis.